RecruitingNot ApplicableNCT06952751

Optimization of the Isolation Protocol for Extracellular Vesicles (EVs) From Human Follicular Fluid


Sponsor

University Hospital, Ghent

Enrollment

4 participants

Start Date

Jul 20, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Background: Extracellular vesicles (EVs) are membrane-bound vesicles found in all biological fluids, containing various regulatory molecules, including microRNAs (miRNAs). It has been suggested that the EVs in human follicular fluid (the fluid surrounding the oocyte within the ovary) play a crucial role in oocyte development through these miRNAs. However, several methods exist for isolating these EVs from follicular fluid. Before further research can be conducted on the pathophysiology and potential diagnostic and therapeutic applications of these EVs and their content, the optimal isolation technique must be determined for future studies. Each method has its advantages and disadvantages, and the purity and efficiency may vary between species and different biological fluids. There are only a limited number of studies comparing the various techniques for application in human follicular fluid. Objective: This study will compare the three most commonly used techniques for isolating EVs: size-based, sedimentation-based (differential ultracentrifugation), and buoyancy-based isolation techniques. Methodology: In this prospective study, follicular fluid will be collected from four patients undergoing transvaginal oocyte retrieval following ovarian stimulation at Ghent University Hospital. Patients over 40 years of age or with endometriosis, adenomyosis, or PCOS (polycystic ovarian syndrome) will not be included in this study. During the oocyte retrieval procedure, follicular fluid will be collected from 2-4 oocytes per patient. Since follicular fluid is not used in the patient's treatment (residual material), it does not affect the treatment. After collection, the three isolation techniques will be applied to each sample. The techniques will be compared in terms of purity (absence of contamination) and efficiency (EV concentration) using transmission electron microscopy, nanoparticle tracking analysis, and western blotting.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 40 Years

Inclusion Criteria1

  • Patients planned for an oocyte retrieval at Ghent University Hospital.

Exclusion Criteria3

  • Diagnosis of endometriosis/adenomyosis
  • Diagnosis of PCOS (Polycystic Ovary Syndrome)
  • Macroscopic blood contamination at oocyte retrieval

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERDifferential ultracentrifugation

Differential ultracentrifugation

OTHEROptiPrep™ density gradient ultracentrifugation

OptiPrep™ density gradient ultracentrifugation

OTHERSize-exclusion chromatography

Size-exclusion chromatography

OTHERCombined techniques

Combined techniques


Locations(1)

Ghent University Hospital

Ghent, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06952751


Related Trials